1. Home
  2. ATYR vs EM Comparison

ATYR vs EM Comparison

Compare ATYR & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.78

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo Smart Share Global Limited

EM

Smart Share Global Limited

HOLD

Current Price

$1.35

Market Cap

286.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
EM
Founded
2005
2017
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
286.5M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
ATYR
EM
Price
$0.78
$1.35
Analyst Decision
Buy
Hold
Analyst Count
6
1
Target Price
$8.75
$1.25
AVG Volume (30 Days)
2.6M
706.0K
Earning Date
11-06-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,000.00
$259,541,587.00
Revenue This Year
N/A
$3.30
Revenue Next Year
$18,728.88
$5.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.68
52 Week High
$7.29
$1.46

Technical Indicators

Market Signals
Indicator
ATYR
EM
Relative Strength Index (RSI) 43.35 45.32
Support Level $0.70 $1.34
Resistance Level $0.83 $1.40
Average True Range (ATR) 0.06 0.03
MACD 0.03 -0.00
Stochastic Oscillator 57.87 21.43

Price Performance

Historical Comparison
ATYR
EM

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

Share on Social Networks: